​

OncoCyte Ownership | Who Owns OncoCyte?

OverviewForecastRevenueFinancialsChartTranscripts

OncoCyte Ownership Summary

OncoCyte is owned by 0.34% institutional investors, 16.32% insiders, and 83.33% retail investors. Defender capital, llc. is the largest institutional shareholder, holding 0.34% of OCX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.54% of its assets in OncoCyte shares.

OCX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOncoCyte0.34%16.32%83.33%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Defender capital, llc.47.08K0.34%$112.05K
Awm investment company---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Defender capital, llc.47.08K0.04%$112.05K
Awm investment company---

Top Buyers

HolderShares% AssetsChange
Defender capital, llc.47.08K0.04%-12.28K
Awm investment company---1.10M

Top Sellers

HolderShares% AssetsChange
Awm investment company---1.10M
Defender capital, llc.47.08K0.04%-12.28K

Sold Out

HolderChange
Awm investment company-1.10M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-47,078-20.68%-183.27%--100.00%1-
Sep 30, 20241-50.00%59,353-94.85%-0.22%1---100.00%
Jun 30, 20242-1,152,39542.24%1312.44%1-1-
Mar 31, 20242-810,171-1.91%1010.58%--100.00%1-
Dec 31, 20232-825,936-0.94%109.42%1-1-50.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv154.88K0.54%-
Vanguard US Total Market Shares ETF154.88K0.54%-
Vanguard Institutional Extnd Mkt Idx Tr85.95K0.30%954.00
Fidelity Extended Market Index84.26K0.29%-537.00
Northern Trust Extended Eq Market Idx11.96K0.07%-
BlackRock Extended Equity Market K9.28K0.07%-4.00
iShares Micro-Cap ETF17.91K0.06%-
NT Ext Equity Mkt Idx Fd - L17.49K0.06%5.53K
Fidelity Series Total Market Index16.50K0.06%1.75K
Spartan Extended Market Index Pool E15.48K0.05%537.00

Recent Insider Transactions

DateNameRoleActivityValue
Feb 07, 2025James Andrea S. Chief Financial OfficerBuy$200.00K
Feb 07, 2025SMITH PATRICK W-Buy$2.21M
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy-
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy-
Feb 06, 2025BROADWOOD PARTNERS, L.P.-Buy$9.24M

Insider Transactions Trends

DateBuySell
2025 Q113-
2024 Q46-
2024 Q3--
2024 Q24-
2023 Q4--

OCX Ownership FAQ

Who Owns OncoCyte?

OncoCyte shareholders are primarily institutional investors at 0.34%, followed by 16.32% insiders and 83.34% retail investors. The average institutional ownership in OncoCyte's industry, Biotech Stocks , is 68.48%, which OncoCyte falls below.

Does Blackrock own OncoCyte?

BlackRock is not among the top 10 institutional shareholders of OncoCyte.

Who is OncoCyte’s biggest shareholder by percentage of total assets invested?

Defender capital, llc is OncoCyte’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 47.08K OncoCyte shares, valued at 112.05K$.

Who is the top mutual fund holder of OncoCyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of OncoCyte shares, with 0.54% of its total shares outstanding invested in 154.88K OncoCyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools